Shin Nippon Biomedical Laboratories, Ltd.

DB:YB3 Stock Report

Market Cap: €386.5m

Shin Nippon Biomedical Laboratories Dividends and Buybacks

Dividend criteria checks 2/6

Shin Nippon Biomedical Laboratories is a dividend paying company with a current yield of 3.34% that is well covered by earnings. Next payment date is on 29th November, 2024 with an ex-dividend date of 27th September, 2024.

Key information

3.3%

Dividend yield

n/a

Buyback Yield

Total Shareholder Yieldn/a
Future Dividend Yield3.3%
Dividend Growth28.5%
Next dividend pay date29 Nov 24
Ex dividend date27 Sep 24
Dividend per share€0.300
Payout ratio53%

Recent dividend and buyback updates

Recent updates

Stability and Growth of Payments

Fetching dividends data

Stable Dividend: Whilst dividend payments have been stable, YB3 has been paying a dividend for less than 10 years.

Growing Dividend: YB3's dividend payments have increased, but the company has only paid a dividend for 6 years.


Dividend Yield vs Market

Shin Nippon Biomedical Laboratories Dividend Yield vs Market
How does YB3 dividend yield compare to the market?
SegmentDividend Yield
Company (YB3)3.3%
Market Bottom 25% (DE)1.7%
Market Top 25% (DE)4.8%
Industry Average (Life Sciences)0.7%
Analyst forecast (YB3) (up to 3 years)3.3%

Notable Dividend: YB3's dividend (3.34%) is higher than the bottom 25% of dividend payers in the German market (1.69%).

High Dividend: YB3's dividend (3.34%) is low compared to the top 25% of dividend payers in the German market (4.76%).


Earnings Payout to Shareholders

Earnings Coverage: With its reasonable payout ratio (53.4%), YB3's dividend payments are covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: YB3 is paying a dividend but the company has no free cash flows.


Discover strong dividend paying companies